Literature DB >> 27038593

Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta.

R Colin Carter1, Helen Wainwright2, Christopher D Molteno3, Michael K Georgieff4, Neil C Dodge5, Fleur Warton6, Ernesta M Meintjes6, Joseph L Jacobson3,6,5, Sandra W Jacobson3,6,5.   

Abstract

BACKGROUND: Animal studies have demonstrated adverse effects of prenatal alcohol exposure on placental development, but few studies have examined these effects in humans. Little is known about effects of prenatal exposure to methamphetamine, marijuana, and cigarette smoking on placental development.
METHODS: Placentas were collected from 103 Cape Coloured (mixed ancestry) pregnant women recruited at their first antenatal clinic visit in Cape Town, South Africa. Sixty-six heavy drinkers and 37 nondrinkers were interviewed about their alcohol, cigarette smoking, and drug use at 3 antenatal visits. A senior pathologist, blinded to exposure status, performed comprehensive pathology examinations on each placenta using a standardized protocol. In multivariable regression models, effects of prenatal exposure were examined on placental size, structure, and presence of infections and meconium.
RESULTS: Drinkers reported a binge pattern of heavy drinking, averaging 8.0 drinks/occasion across pregnancy on 1.4 d/wk. 79.6% smoked cigarettes; 22.3% used marijuana; and 17.5% used methamphetamine. Alcohol exposure was related to decreased placental weight and a smaller placenta-to-birthweight ratio. By contrast, methamphetamine was associated with larger placental weight and a larger placenta-to-birthweight ratio. Marijuana was also associated with larger placental weight. Alcohol exposure was associated with increased risk of placental hemorrhage. Prenatal alcohol, drug, and cigarette use were not associated with chorioamnionitis, villitis, deciduitis, or maternal vascular underperfusion. Alcohol and cigarette smoking were associated with a decreased risk of intrauterine passing of meconium, a sign of acute fetal stress and/or hypoxia; methamphetamine, with an increased risk.
CONCLUSIONS: This is the first human study to show that alcohol, methamphetamine, and marijuana were associated with distinct patterns of pathology, suggesting different mechanisms mediating their effects on placental development. Given the growing body of evidence linking placental abnormalities to neurodevelopmental deficits, these findings may be important in the long-term teratogenic effects of prenatal alcohol and drug exposure.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Cigarette Smoking; Fetal Alcohol Spectrum Disorders; Marijuana; Methamphetamine; Placenta

Mesh:

Substances:

Year:  2016        PMID: 27038593     DOI: 10.1111/acer.13022

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  22 in total

1.  Placental Morphology in Fetal Alcohol Spectrum Disorders.

Authors:  Marlene Tai; Anna Piskorski; Jennifer C W Kao; Lynn A Hess; Suzanne M de la Monte; Füsun Gündoğan
Journal:  Alcohol Alcohol       Date:  2017-03-09       Impact factor: 2.826

2.  Fetal Alcohol Growth Restriction and Cognitive Impairment.

Authors:  R Colin Carter; Joseph L Jacobson; Christopher D Molteno; Neil C Dodge; Ernesta M Meintjes; Sandra W Jacobson
Journal:  Pediatrics       Date:  2016-07-08       Impact factor: 7.124

Review 3.  Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Authors:  Jeffrey R Wozniak; Edward P Riley; Michael E Charness
Journal:  Lancet Neurol       Date:  2019-05-31       Impact factor: 44.182

4.  Prenatal methamphetamine exposure is associated with reduced subcortical volumes in neonates.

Authors:  Fleur L Warton; Ernesta M Meintjes; Christopher M R Warton; Christopher D Molteno; Nadine M Lindinger; R Colin Carter; Lilla Zöllei; Pia Wintermark; Joseph L Jacobson; Andre van der Kouwe; Sandra W Jacobson
Journal:  Neurotoxicol Teratol       Date:  2017-10-22       Impact factor: 3.763

5.  Prenatal methamphetamine exposure is associated with corticostriatal white matter changes in neonates.

Authors:  Fleur L Warton; Paul A Taylor; Christopher M R Warton; Christopher D Molteno; Pia Wintermark; Nadine M Lindinger; Lilla Zöllei; Andre van der Kouwe; Joseph L Jacobson; Sandra W Jacobson; Ernesta M Meintjes
Journal:  Metab Brain Dis       Date:  2017-10-23       Impact factor: 3.584

6.  Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Sandra W Jacobson; R Colin Carter; Christopher D Molteno; Mark E Stanton; Jane S Herbert; Nadine M Lindinger; Catherine E Lewis; Neil C Dodge; H Eugene Hoyme; Steven H Zeisel; Ernesta M Meintjes; Christopher P Duggan; Joseph L Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2018-06-15       Impact factor: 3.455

Review 7.  The Placenta as a Target for Alcohol During Pregnancy: The Close Relation with IGFs Signaling Pathway.

Authors:  Inma Castilla-Cortázar; Fabiola Castorena-Torres; Irene Martín-Estal
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

8.  Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1-11 years: A systematic review.

Authors:  Saida R Sharapova; Elyse Phillips; Karen Sirocco; Jennifer W Kaminski; Rebecca T Leeb; Italia Rolle
Journal:  Paediatr Perinat Epidemiol       Date:  2018-10-18       Impact factor: 3.980

Review 9.  Marijuana Use in Pregnancy: A Review.

Authors:  Rebecca Thompson; Katherine DeJong; Jamie Lo
Journal:  Obstet Gynecol Surv       Date:  2019-07       Impact factor: 2.347

10.  Association of alcohol and other substance-related diagnoses with severe maternal morbidity.

Authors:  Natasia S Courchesne; Laramie R Smith; María Luisa Zúñiga; Christina D Chambers; Mark B Reed; Jerasimos Ballas; Carla B Marienfeld
Journal:  Alcohol Clin Exp Res       Date:  2021-09-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.